Smith J. Jefferson's Form 4 filing
Precision Biosciences Inc (DTIL) · filed May 3, 2024
- Accession no.
- 0000950170-24-053114
- Filed
- May 3, 2024
- Trade date
- Feb 29-May 2, 2024
- Filing delay
- 64 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.59K. It was filed 64 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Smith J. JeffersonCIK 0001770169 | Officer (Chief Research Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 29, 2024 | Common Stock | AGrant or awardAcquired | +1,006 | $12.42 | +$12,494.52 | 67,248 | Direct | |
| May 1, 2024 | Common Stock | MOption exerciseAcquired | +519 | – | – | 67,767 | Direct | |
| May 2, 2024 | Common Stock | SSaleDisposed | −154 | $10.32 | −$1,589.28 | 67,613 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 1, 2024 | Common Stock | MOption exerciseDisposed | −519 | $0.00 | $0 | 519 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.